What is Global Genetically Modified Experimental Animal Model Market?
The Global Genetically Modified Experimental Animal Model Market refers to the industry that focuses on the development, production, and sale of genetically modified animals used for scientific research and experimentation. These animals are specifically engineered to carry altered genes, which can help researchers understand the role of specific genes in health and disease. This market is crucial for advancing medical research, drug development, and understanding genetic disorders. The genetically modified animal models are used in various fields such as pharmaceuticals, biotechnology, and academic research institutions. The market is driven by the increasing demand for personalized medicine, advancements in genetic engineering technologies, and the need for more accurate and reliable animal models to study human diseases. The market encompasses a wide range of genetically modified animals, including mice, rats, zebrafish, and others, each serving unique purposes in research and development.
Genetically Modified Mice, Genetically Modified Rats, Genetically Modified Zebrafish, Others in the Global Genetically Modified Experimental Animal Model Market:
Genetically modified mice are the most commonly used animal models in the Global Genetically Modified Experimental Animal Model Market. These mice are engineered to carry specific genetic mutations that mimic human diseases, making them invaluable for studying the mechanisms of diseases and testing potential treatments. For example, genetically modified mice are used to study cancer, diabetes, cardiovascular diseases, and neurological disorders. They provide a controlled environment to observe the progression of diseases and the effects of new drugs. Genetically modified rats, although less commonly used than mice, are also important in research. They are larger and have more physiological similarities to humans, making them suitable for studying complex diseases and drug metabolism. Genetically modified rats are often used in toxicology studies, cardiovascular research, and behavioral studies. Zebrafish, another important model organism, are used primarily in developmental biology and genetic research. Their transparent embryos allow researchers to observe developmental processes in real-time, and their genetic makeup is surprisingly similar to humans. Zebrafish are used to study gene function, developmental disorders, and the effects of drugs on development. Other genetically modified animals, such as rabbits, pigs, and primates, are used in specific research areas where their unique physiological characteristics are required. For example, genetically modified pigs are used in xenotransplantation research, where their organs are studied for potential transplantation into humans. Primates, due to their close genetic relationship to humans, are used in neuroscience and infectious disease research. Each of these genetically modified animal models plays a crucial role in advancing our understanding of human biology and disease, leading to the development of new treatments and therapies.
Pharmaceutical, Scientific Research, Education, Other in the Global Genetically Modified Experimental Animal Model Market:
The usage of the Global Genetically Modified Experimental Animal Model Market spans several key areas, including pharmaceuticals, scientific research, education, and other specialized fields. In the pharmaceutical industry, genetically modified animal models are essential for drug discovery and development. They are used to test the efficacy and safety of new drugs before they are approved for human use. These models help identify potential side effects and determine the appropriate dosages, significantly reducing the risk of adverse reactions in human trials. In scientific research, genetically modified animals are used to study the genetic basis of diseases, understand disease mechanisms, and identify potential therapeutic targets. Researchers can manipulate specific genes to observe their effects on health and disease, leading to breakthroughs in understanding conditions such as cancer, Alzheimer's disease, and genetic disorders. In the field of education, genetically modified animal models are used in academic institutions to teach students about genetics, molecular biology, and biomedical research. They provide hands-on experience in genetic manipulation techniques and help students understand the complexities of genetic research. Other specialized fields, such as biotechnology and agriculture, also benefit from genetically modified animal models. In biotechnology, these models are used to produce therapeutic proteins, study gene function, and develop gene therapies. In agriculture, genetically modified animals are used to improve livestock traits, such as disease resistance and productivity. Overall, the Global Genetically Modified Experimental Animal Model Market plays a vital role in advancing scientific knowledge, developing new treatments, and improving the quality of life.
Global Genetically Modified Experimental Animal Model Market Outlook:
In 2020, the estimated global market size for model animal sales was valued at USD 8.1 billion. The market is projected to experience significant growth, with an expected compound annual growth rate (CAGR) of 9.4% from 2020 to 2025. Following this period, the market is anticipated to continue its upward trajectory, albeit at a slightly lower CAGR of 7.0% from 2025 to 2030. By the year 2030, the global market for model animal sales is expected to reach a substantial value of USD 17.8 billion. This growth is driven by the increasing demand for genetically modified animal models in various research and development activities, advancements in genetic engineering technologies, and the need for more accurate and reliable models to study human diseases. The market's expansion reflects the critical role that genetically modified animal models play in scientific research, drug development, and understanding genetic disorders.
| Report Metric | Details |
| Report Name | Genetically Modified Experimental Animal Model Market |
| Forecasted market size in 2030 | USD 17.8 billion |
| CAGR | 7.0% |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Joinn Laboratories (China) Co., Ltd., Pharmaron Inc., Shanghai Model Organisms Center, Inc., Sichuan Hengshu Bio-Technology Co.,Ltd., China Environmental Technology and Bioenergy Holdings Limited, GemPharmatech Co., Ltd., Beijing Vital River Laboratory Animal Technology Co., Ltd., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Jackson Laboratory, Hainan Jinlinggang Biotechnology Co., Ltd., Guangdong Landau Biotechnology Co. Ltd., Hubei Topgene Biotechnology Co., Ltd., Envigo, Shanghai Slack Experimental Animal Co., Ltd., Janvier Labs, Taconic Biosciences, Charles River Laboratories, Institute Of Beijing Xieerxin Biology Resource Co.ltd, PolyGene, Cyagen Biosciences, Biocytogen, Hera BioLabs, Ozgene |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
